Wockhardt
WOCKPHARMA
Quick Bite
Price To Earnings Ratio -38.42 | Sector PE 66.19 |
PB Ratio 5.32 | Sector PB 8.82 |
EPS -30.06 | Dividend Yield 0.00 |
Today's Volume 500.198 K | 5 Day Avg. Volume 595.460 K |
PEG Ratio -1.70 | Market Cap. ₹ 19,010.00 Cr. |
Returns Comparison
| Time | WOCKPHARMA | VS | Industry |
|---|---|---|---|
| 1 Day | -1.9% | 0.62% | |
| 1 Week | -2.43% | -3.89% | |
| 1 Month | 6.77% | -7.55% | |
| 6 Months | 78.27% | 14.29% | |
| 1 Year | 357.23% | 48.6% |
Technical Trend
Pivot Levels
Moving Averages
| Period (Days) | SMA | Indication |
|---|---|---|
| 10 | 1230.7 | Bearish |
| 20 | 1165.05 | Bearish |
| 30 | 1111.72 | Bullish |
| 50 | 1069.16 | Bullish |
| 100 | 983.65 | Bullish |
| 200 | 764.73 | Bullish |
Shareholding Updates
Cash Flow
| Annual | FY 2024 | FY 2023 | FY 2022 | ||||
|---|---|---|---|---|---|---|---|
| Operating Activities | 219.00 | 153.00 | 413.00 | ||||
| Investing Activities | -137.00 | -125.00 | -201.00 | ||||
| Financing Activities | 334.00 | -315.00 | -71.00 | ||||
| Net Cash Flow | 416.00 | -287.00 | 141.00 |
All Figures in ₹ Cr., unless mentioned otherwise
Ratios
Income Statement
Balance Sheet
Peer Comparison
| Name | 1D (%) | 1W (%) | 1M (%) | 6M (%) | 1Y (%) |
|---|---|---|---|---|---|
| Wockhardt | -1.9 | -2.43 | 6.77 | 78.27 | 357.23 |
| Aarti Drugs | 0.3 | -4.96 | -7.06 | 3.53 | 4.5 |
| Abbott India | -0.59 | -1.45 | -4.84 | 0.09 | 16.69 |
| Advanced Enzyme Tech | 1.41 | -22.43 | -25.25 | -4.97 | 17.9 |
| Ajanta Pharmaceuticals | 1.43 | -2.7 | -14.64 | 8.27 | 45.89 |
About Wockhardt
Wockhardt Share Price
Wockhardt Limited is a pharmaceutical and biotechnology company. The company's field of activity is the production and distribution of pharmaceutical and biopharmaceutical preparations, active ingredients (API) and vaccines. It produces a variety of dosage forms, including sterile injectable and lyophilized products. The company offers products in the treatment areas of dermatology, cosmetology, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough treatment and diabetology. The company's products across India are Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE, Emrok O , Emrok , FOSCHEK -S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. It has production and research facilities in India, the United States and the United Kingdom, and a manufacturing facility in Ireland.
Wockhardt FAQs
How to Buy Wockhardt Share?
What's Wockhardt share price today?
What is the Market Cap of Wockhardt?
What is the PE and PB ratio of Wockhardt?
What is the 52 Week High and Low of Wockhardt Share?